English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Pluristem’s $30 Million Equity Funding Approved by Innovative Medical Management

Nov. 10, 2016

Israel-based Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, announced on November 10, 2016 that its previously signed and announced term sheet for an investment of approximately $30,000,000 by China-based Innovative Medical Management Co., Ltd., has been approved by Innovative Medical’s Board of Directors and its shareholders. As a result of these approvals, the term sheet is now a binding agreement.